Previous 10 | Next 10 |
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, today announced the Company will partic...
2023-12-26 15:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-01 07:07:06 ET More on Silence Therapeutics Silence Therapeutics jumps after early data for lead candidate Seeking Alpha’s Quant Rating on Silence Therapeutics Historical earnings data for Silence Therapeutics Financial information for Silence ...
Curtis Rambaran, MD, promoted to Chief Medical Officer Marie Wikström Lindholm, PhD, promoted to Chief Scientific Officer Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company comm...
2023-11-14 09:05:43 ET More on Silence Therapeutics Silence Therapeutics jumps after early data for lead candidate Silence Therapeutics GAAP EPS of -9.60p, revenue of £9.1M Seeking Alpha’s Quant Rating on Silence Therapeutics Historical earnings d...
SLN124 phase 1/2 study in polycythemia vera progressing well – data expected in mid-2024 Zerlasiran multiple dose study in patients with high Lp(a) and stable ASCVD showed significant and durable reductions in Lp(a) of up to 99% Fully enrolled zerlasiran phase 2 study in pa...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
Silence Therapeutics Plc (SLN) is expected to report $-0.56 for Q3 2023
2023-11-01 13:43:46 ET More on Silence Therapeutics Silence Therapeutics GAAP EPS of -9.60p, revenue of £9.1M Seeking Alpha’s Quant Rating on Silence Therapeutics Historical earnings data for Silence Therapeutics Financial information for Silence ...
2023-11-01 13:38:15 ET Gainers: Patriot Transportation Holding ( PATI ) +103% . Aldeyra Therapeutics ( ALDX ) +50% . Davis Commodities Ltd. ( DTCK ) +33% . TG Therapeutics ( TGTX ) +32% . Silence Therapeutics ( SLN ) +31% . S...
News, Short Squeeze, Breakout and More Instantly...
Silence Therapeutics Plc Company Name:
SLN Stock Symbol:
NASDAQ Market:
Silence Therapeutics Plc Website:
2024-06-28 10:00:07 ET Keay Nakae from Chardan Capital issued a price target of $55.00 for SLN on 2024-06-28 08:03:00. The adjusted price target was set to $55.00. At the time of the announcement, SLN was trading at $19. The overall price target consensus is at $48.33 wi...
2024-06-28 09:00:06 ET Michael Ulz from Morgan Stanley issued a price target of $49.00 for SLN on 2024-06-28 07:44:00. The adjusted price target was set to $49.00. At the time of the announcement, SLN was trading at $19. The overall price target consensus is at $38.00 wi...
Divesiran eliminated the need for phlebotomy in all well-controlled patients following infrequent dosing and was well tolerated Data support advancing divesiran into Phase 2 Company to host conference call today at 8:30am Eastern Time Silence Therapeutics plc (“Si...